Food, drugs, devices › Philips North America
Device recall: Patient Information Center iX; Software Version Number: 4.5.0
Philips North America (Cambridge, MA) initiated this device recall on 22 Dec 2025; FDA lists 1 product record under event 98217, classified Class II.
FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 85% of the 945 device enforcement events initiated in 2025 carry the same class.
Status: Ongoing. Initiation: voluntary: firm initiated. Philips North America has 30 enforcement events on this register, with a median of 2 product records per event.
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Philips North America, Cambridge, MA.
Reason for recall
"A recent software (SW) patch modifies Mobile Event Notification filter settings without providing any indication to the user when upgrading the system."
Distribution
"Worldwide distribution - US Nationwide and the countries of Austria, Belgium, Brazil, Canada, Czech Republic, Dominican Rep, Finland, France, Germany, Greece, Hungary, India, Italy, Japan, Jordan,…"
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| Z-1156-2026 | Patient Information Center iX; Software Version Number: 4.5.0 | 146 units (41 US, 105 OUS) | Class II | Ongoing | 28 Jan 2026 |
Context
Other enforcement events for Philips North America
All 30 events for Philips North America
Questions and answers
Why was this device recalled?
FDA's record gives the reason for recall as: "A recent software (SW) patch modifies Mobile Event Notification filter settings without providing any indication to the user when upgrading the system."
What does Class II mean?
FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Where was the product distributed?
FDA's distribution pattern field reads: "Worldwide distribution - US Nationwide and the countries of Austria, Belgium, Brazil, Canada, Czech Republic, Dominican Rep, Finland, France, Germany, Greece, Hungary, India, Italy, Japan, Jordan,…"
Is the recall still ongoing?
FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.